Global Geriatric Medicines Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: GA81DCCB2215EN
QYResearch

Abstracts

This report focuses on the global Geriatric Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Geriatric Medicines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Eli Lilly and Company
• AstraZeneca
• Boehringer Ingelheim
• Abbott Laboratories
• Sanofi
• Bristol-Myers Squibb
• Merck
• Novartis
• Pfizer
• GSK

Market segment by Type, the product can be split into

• Analgesics
• Antihypertensives
• Statins
• Antidiabetics
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotics
• Antidepressants

Market segment by Application, split into

• Cardiovascular diseases
• Arthritis
• Neurological Disorders
• Cancer
• Osteoporosis
• Respiratory

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Geriatric Medicines status, future forecast, growth opportunity, key market and key players.
• To present the Geriatric Medicines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Geriatric Medicines are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Geriatric Medicines Revenue
1.4 Market Analysis by Type
  1.4.1 Global Geriatric Medicines Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Analgesics
  1.4.3 Antihypertensives
  1.4.4 Statins
  1.4.5 Antidiabetics
  1.4.6 Proton Pump Inhibitor
  1.4.7 Anticoagulant
  1.4.8 Antipsychotics
  1.4.9 Antidepressants
1.5 Market by Application
  1.5.1 Global Geriatric Medicines Market Share by Application: 2020 VS 2026
  1.5.2 Cardiovascular diseases
  1.5.3 Arthritis
  1.5.4 Neurological Disorders
  1.5.5 Cancer
  1.5.6 Osteoporosis
  1.5.7 Respiratory
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Geriatric Medicines Market Perspective (2015-2026)
2.2 Geriatric Medicines Growth Trends by Regions
  2.2.1 Geriatric Medicines Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Geriatric Medicines Historic Market Share by Regions (2015-2020)
  2.2.3 Geriatric Medicines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Geriatric Medicines Market Growth Strategy
  2.3.6 Primary Interviews with Key Geriatric Medicines Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Geriatric Medicines Players by Market Size
  3.1.1 Global Top Geriatric Medicines Players by Revenue (2015-2020)
  3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2015-2020)
  3.1.3 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Geriatric Medicines Market Concentration Ratio
  3.2.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2019
3.3 Geriatric Medicines Key Players Head office and Area Served
3.4 Key Players Geriatric Medicines Product Solution and Service
3.5 Date of Enter into Geriatric Medicines Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Geriatric Medicines Historic Market Size by Type (2015-2020)
4.2 Global Geriatric Medicines Forecasted Market Size by Type (2021-2026)

5 GERIATRIC MEDICINES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Geriatric Medicines Market Size by Application (2015-2020)
5.2 Global Geriatric Medicines Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Geriatric Medicines Market Size (2015-2020)
6.2 Geriatric Medicines Key Players in North America (2019-2020)
6.3 North America Geriatric Medicines Market Size by Type (2015-2020)
6.4 North America Geriatric Medicines Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Geriatric Medicines Market Size (2015-2020)
7.2 Geriatric Medicines Key Players in Europe (2019-2020)
7.3 Europe Geriatric Medicines Market Size by Type (2015-2020)
7.4 Europe Geriatric Medicines Market Size by Application (2015-2020)

8 CHINA

8.1 China Geriatric Medicines Market Size (2015-2020)
8.2 Geriatric Medicines Key Players in China (2019-2020)
8.3 China Geriatric Medicines Market Size by Type (2015-2020)
8.4 China Geriatric Medicines Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Geriatric Medicines Market Size (2015-2020)
9.2 Geriatric Medicines Key Players in Japan (2019-2020)
9.3 Japan Geriatric Medicines Market Size by Type (2015-2020)
9.4 Japan Geriatric Medicines Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Geriatric Medicines Market Size (2015-2020)
10.2 Geriatric Medicines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Geriatric Medicines Market Size by Type (2015-2020)
10.4 Southeast Asia Geriatric Medicines Market Size by Application (2015-2020)

11 INDIA

11.1 India Geriatric Medicines Market Size (2015-2020)
11.2 Geriatric Medicines Key Players in India (2019-2020)
11.3 India Geriatric Medicines Market Size by Type (2015-2020)
11.4 India Geriatric Medicines Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Geriatric Medicines Market Size (2015-2020)
12.2 Geriatric Medicines Key Players in Central & South America (2019-2020)
12.3 Central & South America Geriatric Medicines Market Size by Type (2015-2020)
12.4 Central & South America Geriatric Medicines Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Eli Lilly and Company
  13.1.1 Eli Lilly and Company Company Details
  13.1.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.1.3 Eli Lilly and Company Geriatric Medicines Introduction
  13.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2015-2020))
  13.1.5 Eli Lilly and Company Recent Development
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Details
  13.2.2 AstraZeneca Business Overview and Its Total Revenue
  13.2.3 AstraZeneca Geriatric Medicines Introduction
  13.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2015-2020)
  13.2.5 AstraZeneca Recent Development
13.3 Boehringer Ingelheim
  13.3.1 Boehringer Ingelheim Company Details
  13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.3.3 Boehringer Ingelheim Geriatric Medicines Introduction
  13.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2015-2020)
  13.3.5 Boehringer Ingelheim Recent Development
13.4 Abbott Laboratories
  13.4.1 Abbott Laboratories Company Details
  13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.4.3 Abbott Laboratories Geriatric Medicines Introduction
  13.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2015-2020)
  13.4.5 Abbott Laboratories Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview and Its Total Revenue
  13.5.3 Sanofi Geriatric Medicines Introduction
  13.5.4 Sanofi Revenue in Geriatric Medicines Business (2015-2020)
  13.5.5 Sanofi Recent Development
13.6 Bristol-Myers Squibb
  13.6.1 Bristol-Myers Squibb Company Details
  13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction
  13.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2015-2020)
  13.6.5 Bristol-Myers Squibb Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview and Its Total Revenue
  13.7.3 Merck Geriatric Medicines Introduction
  13.7.4 Merck Revenue in Geriatric Medicines Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 Novartis
  13.8.1 Novartis Company Details
  13.8.2 Novartis Business Overview and Its Total Revenue
  13.8.3 Novartis Geriatric Medicines Introduction
  13.8.4 Novartis Revenue in Geriatric Medicines Business (2015-2020)
  13.8.5 Novartis Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview and Its Total Revenue
  13.9.3 Pfizer Geriatric Medicines Introduction
  13.9.4 Pfizer Revenue in Geriatric Medicines Business (2015-2020)
  13.9.5 Pfizer Recent Development
13.10 GSK
  13.10.1 GSK Company Details
  13.10.2 GSK Business Overview and Its Total Revenue
  13.10.3 GSK Geriatric Medicines Introduction
  13.10.4 GSK Revenue in Geriatric Medicines Business (2015-2020)
  13.10.5 GSK Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Geriatric Medicines Key Market Segments
Table 2. Key Players Covered: Ranking by Geriatric Medicines Revenue
Table 3. Ranking of Global Top Geriatric Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Geriatric Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analgesics
Table 6. Key Players of Antihypertensives
Table 7. Key Players of Statins
Table 8. Key Players of Antidiabetics
Table 9. Key Players of Proton Pump Inhibitor
Table 10. Key Players of Anticoagulant
Table 11. Key Players of Antipsychotics
Table 12. Key Players of Antidepressants
Table 13. Global Geriatric Medicines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Geriatric Medicines Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Geriatric Medicines Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Geriatric Medicines Market Share by Regions (2015-2020)
Table 17. Global Geriatric Medicines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Geriatric Medicines Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Geriatric Medicines Market Growth Strategy
Table 23. Main Points Interviewed from Key Geriatric Medicines Players
Table 24. Global Geriatric Medicines Revenue by Players (2015-2020) (Million US$)
Table 25. Global Geriatric Medicines Market Share by Players (2015-2020)
Table 26. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicines as of 2019)
Table 27. Global Geriatric Medicines by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Geriatric Medicines Product Solution and Service
Table 30. Date of Enter into Geriatric Medicines Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 33. Global Geriatric Medicines Market Size Share by Type (2015-2020)
Table 34. Global Geriatric Medicines Revenue Market Share by Type (2021-2026)
Table 35. Global Geriatric Medicines Market Size Share by Application (2015-2020)
Table 36. Global Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 37. Global Geriatric Medicines Market Size Share by Application (2021-2026)
Table 38. North America Key Players Geriatric Medicines Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Geriatric Medicines Market Share (2019-2020)
Table 40. North America Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 41. North America Geriatric Medicines Market Share by Type (2015-2020)
Table 42. North America Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 43. North America Geriatric Medicines Market Share by Application (2015-2020)
Table 44. Europe Key Players Geriatric Medicines Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Geriatric Medicines Market Share (2019-2020)
Table 46. Europe Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Geriatric Medicines Market Share by Type (2015-2020)
Table 48. Europe Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Geriatric Medicines Market Share by Application (2015-2020)
Table 50. China Key Players Geriatric Medicines Revenue (2019-2020) (Million US$)
Table 51. China Key Players Geriatric Medicines Market Share (2019-2020)
Table 52. China Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 53. China Geriatric Medicines Market Share by Type (2015-2020)
Table 54. China Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 55. China Geriatric Medicines Market Share by Application (2015-2020)
Table 56. Japan Key Players Geriatric Medicines Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Geriatric Medicines Market Share (2019-2020)
Table 58. Japan Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Geriatric Medicines Market Share by Type (2015-2020)
Table 60. Japan Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Geriatric Medicines Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Geriatric Medicines Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Geriatric Medicines Market Share (2019-2020)
Table 64. Southeast Asia Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Geriatric Medicines Market Share by Type (2015-2020)
Table 66. Southeast Asia Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Geriatric Medicines Market Share by Application (2015-2020)
Table 68. India Key Players Geriatric Medicines Revenue (2019-2020) (Million US$)
Table 69. India Key Players Geriatric Medicines Market Share (2019-2020)
Table 70. India Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 71. India Geriatric Medicines Market Share by Type (2015-2020)
Table 72. India Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 73. India Geriatric Medicines Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Geriatric Medicines Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Geriatric Medicines Market Share (2019-2020)
Table 76. Central & South America Geriatric Medicines Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Geriatric Medicines Market Share by Type (2015-2020)
Table 78. Central & South America Geriatric Medicines Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Geriatric Medicines Market Share by Application (2015-2020)
Table 80. Eli Lilly and Company Company Details
Table 81. Eli Lilly and Company Business Overview
Table 82. Eli Lilly and Company Product
Table 83. Eli Lilly and Company Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 84. Eli Lilly and Company Recent Development
Table 85. AstraZeneca Company Details
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Product
Table 88. AstraZeneca Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 89. AstraZeneca Recent Development
Table 90. Boehringer Ingelheim Company Details
Table 91. Boehringer Ingelheim Business Overview
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 94. Boehringer Ingelheim Recent Development
Table 95. Abbott Laboratories Company Details
Table 96. Abbott Laboratories Business Overview
Table 97. Abbott Laboratories Product
Table 98. Abbott Laboratories Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 99. Abbott Laboratories Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Product
Table 103. Sanofi Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 104. Sanofi Recent Development
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Product
Table 108. Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Product
Table 113. Merck Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 114. Merck Recent Development
Table 115. Novartis Business Overview
Table 116. Novartis Product
Table 117. Novartis Company Details
Table 118. Novartis Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 119. Novartis Recent Development
Table 120. Pfizer Company Details
Table 121. Pfizer Business Overview
Table 122. Pfizer Product
Table 123. Pfizer Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 124. Pfizer Recent Development
Table 125. GSK Company Details
Table 126. GSK Business Overview
Table 127. GSK Product
Table 128. GSK Revenue in Geriatric Medicines Business (2015-2020) (Million US$)
Table 129. GSK Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Geriatric Medicines Market Share by Type: 2020 VS 2026
Figure 2. Analgesics Features
Figure 3. Antihypertensives Features
Figure 4. Statins Features
Figure 5. Antidiabetics Features
Figure 6. Proton Pump Inhibitor Features
Figure 7. Anticoagulant Features
Figure 8. Antipsychotics Features
Figure 9. Antidepressants Features
Figure 10. Global Geriatric Medicines Market Share by Application: 2020 VS 2026
Figure 11. Cardiovascular diseases Case Studies
Figure 12. Arthritis Case Studies
Figure 13. Neurological Disorders Case Studies
Figure 14. Cancer Case Studies
Figure 15. Osteoporosis Case Studies
Figure 16. Respiratory Case Studies
Figure 17. Geriatric Medicines Report Years Considered
Figure 18. Global Geriatric Medicines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Geriatric Medicines Market Share by Regions: 2020 VS 2026
Figure 20. Global Geriatric Medicines Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Geriatric Medicines Market Share by Players in 2019
Figure 23. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicines as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Geriatric Medicines Revenue in 2019
Figure 25. North America Geriatric Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Geriatric Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Geriatric Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Geriatric Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Geriatric Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Geriatric Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Geriatric Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Eli Lilly and Company Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 34. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AstraZeneca Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 36. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 38. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Abbott Laboratories Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 42. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 44. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Merck Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 46. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Novartis Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pfizer Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GSK Revenue Growth Rate in Geriatric Medicines Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed